Increased risk of thrombosis in patients with MPN is due to resistance to activated C protein, which correlates with homozygous JAK2 status, with protrombotic role.[6] Monocytes from JAK2 positive patients with PV and especially ET have an increased capacity for synthesis of tissue factor. This evidence concerns the gene JAK2 and myeloproliferative disorder.